Insights

Tuberous sclerosis, an autosomal dominant disorder, arises from mutations in TSC1 or TSC2 genes. Early identification of subtle symptoms like facial angiofibromas in children is crucial for timely diagnosis and management.

Area of Science:

  • Genetics
  • Dermatology
  • Pediatrics

Background:

  • Tuberous sclerosis is an autosomal dominant genetic disorder.
  • It is caused by mutations in the tumor suppressor genes TSC1 and TSC2.
  • The disease affects multiple organs, including the skin, brain, heart, kidneys, and lungs.

Observation:

  • A two-year-old girl presented with hypopigmented macules (ash leaf spots) and facial angiofibromas.
  • Her mother had a known diagnosis of tuberous sclerosis.
  • The patient's symptoms were specifically investigated due to her family history.

Findings:

  • The case highlights the presentation of tuberous sclerosis in a young child.
  • Subtle angiofibromas can be easily missed in pediatric patients.
  • Early detection is critical, even when symptoms are not immediately obvious.

Implications:

  • Emphasizes the importance of vigilant dermatological screening in pediatric tuberous sclerosis cases.
  • Highlights the role of genetic counseling and family history in diagnosing rare genetic disorders.
  • Underscores the need for increased awareness among healthcare providers regarding subtle early signs of tuberous sclerosis.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...